Inservice- Biosimilars

July 14, 2022

Many infusion patients are being switched from Remicade to one of the biosimilars. The nurses in the infusion center do not always have answers for patient/ family concerns and want to be consistent with what the GI providers are telling them. This talk will review what biosimilars are and  common patient concerns around biosimilars.

Target Audience

RN

Learning Objectives

Following this presentation:

The learner will define biosimilars 

The learner will discuss common patient concerns around biosimilars

Course summary
Available credit: 
  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.00 Attendance
Course opens: 
07/14/2022
Course expires: 
07/28/2022
Event starts: 
07/14/2022 - 7:00am EDT
Event ends: 
07/14/2022 - 4:00pm EDT
Add to calendar: 
UPMC: Children's Hospital of Pittsburgh
Pittsburgh, PA
United States

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.  

Available Credit

  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.00 Attendance
Please login or register to take this course.